Upregulation of miR-1294 inhibits inflammation in atopic dermatitis by suppressing NF-κB pathway activation [53] and promotes the development of autoimmune disorders by regulating the release of pro-inflammatory cytokines [54]. Here, NFKB1 is linked to atopic eczema.